These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 26336202)

  • 1. Remote Assessment of Cognitive Function in Juvenile Neuronal Ceroid Lipofuscinosis (Batten disease): A Pilot Study of Feasibility and Reliability.
    Ragbeer SN; Augustine EF; Mink JW; Thatcher AR; Vierhile AE; Adams HR
    J Child Neurol; 2016 Mar; 31(4):481-7. PubMed ID: 26336202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Unified Batten Disease Rating Scale (UBDRS): Validation and reliability in an independent CLN3 disease sample.
    Wibbeler E; Nickel M; Schwering C; Schulz A; Mink JW
    Eur J Paediatr Neurol; 2022 May; 38():62-65. PubMed ID: 35427884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantifying physical decline in juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Kwon JM; Adams H; Rothberg PG; Augustine EF; Marshall FJ; Deblieck EA; Vierhile A; Beck CA; Newhouse NJ; Cialone J; Levy E; Ramirez-Montealegre D; Dure LS; Rose KR; Mink JW
    Neurology; 2011 Nov; 77(20):1801-7. PubMed ID: 22013180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel c.1135_1138delCTGT mutation in CLN3 leads to juvenile neuronal ceroid lipofuscinosis.
    Drack AV; Miller JN; Pearce DA
    J Child Neurol; 2013 Sep; 28(9):1112-6. PubMed ID: 23877479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methodology of clinical research in rare diseases: development of a research program in juvenile neuronal ceroid lipofuscinosis (JNCL) via creation of a patient registry and collaboration with patient advocates.
    de Blieck EA; Augustine EF; Marshall FJ; Adams H; Cialone J; Dure L; Kwon JM; Newhouse N; Rose K; Rothberg PG; Vierhile A; Mink JW;
    Contemp Clin Trials; 2013 Jul; 35(2):48-54. PubMed ID: 23628560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect.
    de los Reyes E; Dyken PR; Phillips P; Brodsky M; Bates S; Glasier C; Mrak RE
    J Child Neurol; 2004 Jan; 19(1):42-6. PubMed ID: 15032383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical rating scale for Batten disease: reliable and relevant for clinical trials.
    Marshall FJ; de Blieck EA; Mink JW; Dure L; Adams H; Messing S; Rothberg PG; Levy E; McDonough T; DeYoung J; Wang M; Ramirez-Montealegre D; Kwon JM; Pearce DA
    Neurology; 2005 Jul; 65(2):275-9. PubMed ID: 16043799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene symbol: CLN3. Disease: Juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Leman AR; Pearce DA; Rothberg PG
    Hum Genet; 2005 May; 116(6):544. PubMed ID: 15991331
    [No Abstract]   [Full Text] [Related]  

  • 9. Gene symbol: CLN3. Disease: juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Leman AR; Pearce DA; Rothberg PG
    Hum Genet; 2005 Feb; 116(3):236. PubMed ID: 15818814
    [No Abstract]   [Full Text] [Related]  

  • 10. Juvenile neuronal ceroid lipofuscinosis (Batten disease) CLN3 mutation (Chrom 16p11.2) with different phenotypes in a sibling pair and low intensity in vivo autofluorescence.
    Mantel I; Brantley MA; Bellmann C; Robson AG; Holder GE; Taylor A; Anderson G; Moore AT
    Klin Monbl Augenheilkd; 2004 May; 221(5):427-30. PubMed ID: 15162299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissimilar neuropsychiatric presentations of two siblings with juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Lee TS; Poon SH; Chang P
    J Neuropsychiatry Clin Neurosci; 2010; 22(1):123.E14-5. PubMed ID: 20160229
    [No Abstract]   [Full Text] [Related]  

  • 12. Neuropsychological symptoms of juvenile-onset batten disease: experiences from 2 studies.
    Adams HR; Kwon J; Marshall FJ; de Blieck EA; Pearce DA; Mink JW
    J Child Neurol; 2007 May; 22(5):621-7. PubMed ID: 17690071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotype does not predict severity of behavioural phenotype in juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Adams HR; Beck CA; Levy E; Jordan R; Kwon JM; Marshall FJ; Vierhile A; Augustine EF; de Blieck EA; Pearce DA; Mink JW
    Dev Med Child Neurol; 2010 Jul; 52(7):637-43. PubMed ID: 20187884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunosuppressive Treatment for Retinal Degeneration in Juvenile Neuronal Ceroid Lipofuscinosis (Juvenile Batten Disease).
    Drack AV; Mullins RF; Pfeifer WL; Augustine EF; Stasheff SF; Hong SD
    Ophthalmic Genet; 2015; 36(4):359-64. PubMed ID: 24547931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A knock-in reporter mouse model for Batten disease reveals predominant expression of Cln3 in visual, limbic and subcortical motor structures.
    Ding SL; Tecedor L; Stein CS; Davidson BL
    Neurobiol Dis; 2011 Feb; 41(2):237-48. PubMed ID: 20875858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defective lysosomal arginine transport in juvenile Batten disease.
    Ramirez-Montealegre D; Pearce DA
    Hum Mol Genet; 2005 Dec; 14(23):3759-73. PubMed ID: 16251196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation af Cln3 associated with delayed-classic juvenile ceroid lipofuscinois and autophagic vacuolar myopathy.
    Licchetta L; Bisulli F; Fietz M; Valentino ML; Morbin M; Mostacci B; Oliver KL; Berkovic SF; Tinuper P
    Eur J Med Genet; 2015 Oct; 58(10):540-4. PubMed ID: 26360874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid detection of the major deletion in the Batten disease gene CLN3 by allele specific PCR.
    Taschner PE; de Vos N; Breuning MH
    J Med Genet; 1997 Nov; 34(11):955-6. PubMed ID: 9391897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X).
    Sarpong A; Schottmann G; Rüther K; Stoltenburg G; Kohlschütter A; Hübner C; Schuelke M
    Clin Genet; 2009 Jul; 76(1):38-45. PubMed ID: 19489875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional brain atrophy in mouse models of neuronal ceroid lipofuscinosis: a new rostrocaudal perspective.
    Kühl TG; Dihanich S; Wong AM; Cooper JD
    J Child Neurol; 2013 Sep; 28(9):1117-22. PubMed ID: 24014506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.